株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

米国の逆流防止装置市場

Anti-Reflux Devices Market Report | United States | 2019-2025 | MedCore

発行 iData Research Inc. 商品コード 379007
出版日 ページ情報 英文 70 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.13円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の逆流防止装置市場 Anti-Reflux Devices Market Report | United States | 2019-2025 | MedCore
出版日: 2019年02月01日 ページ情報: 英文 70 Pages
概要

当レポートでは、米国の逆流防止装置市場について調査分析し、市場概要、市場分析と予測、促進要因・阻害要因、競合分析など、体系的な情報を提供しています。

エグゼクティブサマリー

米国の消化器内視鏡装置市場の概要

競合分析

市場動向

市場の発展

処置数

調査訴訟

対象市場

調査手法

疾患の概要

  • 基本構造
  • 消化器疾患:治療・診断
  • 患者の人口統計

製品の評価

  • 製品ポートフォリオ
  • 規制上の問題・リコール
  • 治験
  • 製品パイプライン

逆流防止装置市場

  • 市場分析と予測
  • 潜在的市場
  • 促進要因・阻害要因
  • 競合市場シェア分析

略語

図表

LIST OF CHARTS

  • Chart 4 1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 - 2025 2
  • Chart 4 2: Endoscopic Gastrointestinal Device Market Overview, U.S., 2018 & 2025 2
  • Chart 3 1: Anti-Reflux Device Market, U.S., 2015 - 2025 55
  • Chart 3 2: Leading Competitors, Anti-Reflux Device Market, U.S., 2018 60

LIST OF FIGURES

  • Figure 4 1: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (1 of 3) 3
  • Figure 4 2: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (2 of 3) 4
  • Figure 4 3: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (3 of 3) 4
  • Figure 4 4: Companies Researched in this Report 5
  • Figure 4 5: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (1 of 2) 6
  • Figure 4 6: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (2 of 2) 7
  • Figure 4 7: Recent Events in the Endoscopic Gastrointestinal Device Market, U.S., 2016 - 2018 8
  • Figure 4 8: Endoscopic Gastrointestinal Device Procedures Covered 9
  • Figure 4 9: Procedure Codes Investigated 10
  • Figure 4 10: Endoscopic Gastrointestinal Device Markets Covered (1 of 3) 11
  • Figure 4 11: Endoscopic Gastrointestinal Device Markets Covered (2 of 3) 12
  • Figure 4 12: Endoscopic Gastrointestinal Device Markets Covered (3 of 3) 13
  • Figure 4 13: Key Report Updates 14
  • Figure 4 14: Version History 15
  • Figure 2 1: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 - 2010 43
  • Figure 3 1: Market Opportunity, Anti-Reflux Device Market, U.S., 2015 - 2025 52
  • Figure 3 2: Anti-Reflux Device Market, U.S., 2015 - 2025 54
  • Figure 3 3: Drivers and Limiters, Anti-Reflux Device Market, U.S., 2018 57
  • Figure 3 4: Leading Competitors, Anti-Reflux Device Market, U.S., 2018 59
目次
Product Code: iDATA_USGI19_MC_AR

Gastroesophageal reflux disease (GERD) is a condition where stomach acids, as well as other stomach contents, rise into the esophagus from the stomach. Some of the more commonly experienced symptoms of GERD are esophageal irritation, nausea, heartburn and regurgitation. If GERD is left untreated, it may lead to more serious conditions, such as Barrett's esophagus, ulcers, strictures, infections and even asthma.

The value of the anti-reflux device market increased in 2018, and strong growth is expected to continue over the forecast period. Growth will be driven by consistent unit sales growth and ASP appreciation. Anti-reflux devices covered in this analysis use a variety of procedure techniques to treat GERD, including transoral incisionless fundoplication (TIF), transesophageal radiofrequency and the LINX technique.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES IV

LIST OF CHARTS V

EXECUTIVE SUMMARY 1

U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 3

MARKET TRENDS 6

MARKET DEVELOPMENTS 8

PROCEDURE NUMBERS 9

PROCEDURE CODES INVESTIGATED 10

MARKETS INCLUDED 11

KEY REPORT UPDATES 14

VERSION HISTORY 15

RESEARCH METHODOLOGY 16

    • Step 1: Project Initiation & Team Selection 16
    • Step 2: Prepare Data Systems and Perform Secondary Research 19
    • Step 3: Preparation for Interviews & Questionnaire Design 21
    • Step 4: Performing Primary Research 22
    • Step 5: Research Analysis: Establishing Baseline Estimates 24
    • Step 6: Market Forecast and Analysis 25
    • Step 7: Identify Strategic Opportunities 27
    • Step 8: Final Review and Market Release 28
    • Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

  • 2.1 BASIC ANATOMY 30
  • 2.2 DISEASE TREATMENT & DIAGNOSTICS 32
    • 2.2.1 Gastroesophageal Reflux Disease 32
    • 2.2.2 Barrett's Esophagus 34
    • 2.2.3 GI Cancer 34
    • 2.2.4 GI bleeding 37
    • 2.2.5 Bile Duct Diseases 38
    • 2.2.6 Crohn's Disease 39
    • 2.2.7 Peptic Ulcer Disease 40
    • 2.2.8 Intestinal Pseudo-Obstruction and Ogilvie Syndrome 40
  • 2.3 PATIENT DEMOGRAPHICS 42
    • 2.3.1 GI Disorders 42
      • 2.3.1.1 General Statistics of GI Disorders for Different Years for the United States 43
      • 2.3.1.2 Abdominal Wall Hernia 44
      • 2.3.1.3 Chronic Constipation 45
      • 2.3.1.4 Diverticular Disease 45
      • 2.3.1.5 Prescriptions 45
      • 2.3.1.6 Gastroesophageal Reflux Disease 45
      • 2.3.1.7 Gastrointestinal Infections 46
      • 2.3.1.8 Hemorrhoids 46
      • 2.3.1.9 Inflammatory Bowel Disease 46
      • 2.3.1.10 Liver Disease 47
      • 2.3.1.11 Pancreatitis 47
      • 2.3.1.12 Peptic Ulcer Diseases 47
    • 2.3.2 GI Cancers 48

ANTI-REFLUX DEVICE MARKET 49

  • 3.1 INTRODUCTION 49
  • 3.2 MARKET LANDSCAPE 51
  • 3.3 MARKET ANALYSIS AND FORECAST 53
  • 3.4 DRIVERS AND LIMITERS 56
    • 3.4.1 Market Drivers 56
    • 3.4.2 Market Limiters 57
  • 3.5 COMPETITIVE MARKET SHARE ANALYSIS 58

ABBREVIATIONS 61

Back to Top